For availing loan facility to repay existing debt obligations and fund capex
Jubilant Pharmova's wholly owned subsidiary Jubilant Pharma, today announced that its subsidiary Jubilant Pharma Holdings Inc. (JPHI) has entered in an agreement with Standard Chartered Bank for a five year loan facility for repayment of existing term loan and bonds aggregating USD 350 million and additional tranche of USD 50 million for future growth capex.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content